BamSEC and AlphaSense Join Forces
Learn More

ArriVent BioPharma Inc. – Material Contracts

NASDAQ: AVBP    
Share price (6/1/26): $30.68    
Market cap (6/1/26): $1.429 billion

Material Contracts Filter

EX-10.2
from 10-Q 3 pages Amendment No. 1 to the Amended and Restated Research Collaboration Agreement
12/34/56
EX-10.1
from 10-Q 3 pages ArriVent Biopharma, Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 10-Q 3 pages ArriVent Biopharma, Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.3
from 10-Q 3 pages ArriVent Biopharma, Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 10-Q 70 pages ​ ​ Exclusive License Agreement
12/34/56
EX-10.1
from 10-Q 46 pages Amended and Restated Research Collaboration Agreement
12/34/56
EX-10.1
from 10-Q 55 pages Background Article 1 Definitions
12/34/56
EX-10.4
from S-1/A 9 pages ArriVent Biopharma, Inc. Executive Severance Plan
12/34/56
EX-10.3
from S-1/A 37 pages ArriVent Biopharma, Inc. 2024 Employee, Director and Consultant Equity Incentive Plan
12/34/56
EX-10.15
from S-1 34 pages Clinical Collaboration Agreement
12/34/56
EX-10.14
from S-1 53 pages Research Collaboration Agreement
12/34/56
EX-10.13
from S-1 14 pages Joint Clinical Collaboration Agreement
12/34/56
EX-10.12
from S-1 69 pages [***] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because the Information (I) Is Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential
12/34/56
EX-10.11
from S-1 3 pages Material contract
12/34/56
EX-10.10
from S-1 3 pages Material contract
12/34/56
EX-10.9
from S-1 3 pages Material contract
12/34/56
EX-10.8
from S-1 3 pages Material contract
12/34/56
EX-10.7
from S-1 3 pages Material contract
12/34/56
EX-10.6
from S-1 3 pages ArriVent Biopharma, Inc. Clawback Policy
12/34/56
EX-10.5
from S-1 3 pages ArriVent Biopharma, Inc. Non-Employee Director Compensation Policy
12/34/56